US Patent Issued to Etagen Pharma on July 15 for "Compositions and methods for editing nucleic acids in cells utilizing oligonucleotides" (Massachusetts, California Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,359,197, issued on July 15, was assigned to Etagen Pharma Inc. (Sudbury, Mass.).

"Compositions and methods for editing nucleic acids in cells utilizing oligonucleotides" was invented by Tod M. Woolf (Sudbury, Mass.), Alexandre V. Lebedev (Sudbury, Mass.) and Richard I. Hogrefe (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes compositions and methods for the treatment of a medical condition or disease utilizing editing oligonucleotides. The editing oligonucleotides contain an oligonucleotide strand of about 10 to about 50 nucleotides on each side of the editing moiety which may contain a sugar or linker that positi...